Cell Line Development Market

Category : Healthcare & Life Sciences Reports | Delivery Format : PDF,PPT | Publisher: Reports and Insights | Pages : 279-321

Summarized Info Details
Base Year: 2020 Forecast Period: 2021-2028
Key Geographies:
  • North America, Latin America, Europe, Asia Pacific, Middle East and Africa
Market Segmentation:
  • The global Cell Line Development market is segmented on the basis of product type, source type, end user, cell lines, and region
Key Players:

American Type Culture Collection, Lonza Group AG, Thermo Fisher Scientific, Inc., GE Healthcare, Sigma Aldrich Corporation, Selexis SA, European Collection of Cell Cultures (ECACC), Corning, Inc., Wuxi App Tec, Inc., Sartorious AG and among others

Key Dynamics:
  • Rapidly growing prevalence of cancer among the population around the world
Market Size: US$ xxxx Mn CAGR (2021 -2028): xx%

To learn more about this report, request a free sample copy

Cell Line Development Market Overview

The report is titled as ‘Cell Line Development Market: Opportunity Analysis and Future Assessment 2020-2028’. An overview of conceptual frameworks, analytical approaches of the Cell Line Development market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market. Cell Line Development market is expected to grow with significant rate in the near future.

 

In 2020, global cell line development market was valued at US$ XXX Mn and expected to grow significantly at a CAGR of XXX % over the forecast period

Cell Line Development Introduction

The cell line is basically an customary cell culture, whither the cells proliferate in the appropriate growth medium and scope for growth. Various cell lines are formed from various cells. Cell lines allow progressive changes in the physiology, structure, and genetic makeup of cells under a custom-built environment. Cell line development is considerably a significant technology in the domain of life sciences. Stabilized cell lines are employed for diverse applications comprising monoclonal antibody and recombinant protein productions, drug screening, and gene functional studies.

Cell Line Development Market Dynamics

One of the major factors that is principally boosting the demand of cell line development is the rapidly growing prevalence of cancer among the population around the world. According to the World Health Organization (WHO), Cancer was a prime cause of death all across the world, accounting for around 10 million deaths in 2020. Owing to which, the global cell line development market is projected to rise considerably in the near future. In addition to that, the swift adoption of regenerative medicines and rising investments in R&D by biotechnology and pharmaceutical companies is further expected to offer major breakthroughs to the market growth in the following years. By the same token, the constant research in drug discovery activities is also estimated to accelerate the cell line development market in the future years. Having said that, the risk of cell line contamination is likely to hamper the market growth in the coming years.

Reports & Insights Overview

The non-identical approach of Reports and Insights stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give better opportunity for the customers to put their effort.

 

A research report on the Cell Line Development market by Reports and Insights is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that supports market and the factors that are acting as impedance for the growth of the market. Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.

Cell Line Development Market Segmentation

The global Cell Line Development market is segmented on the basis of product type, source type, end user, cell lines, and region

 

By Product Type:

Reagent and Media

Equipment

Accessories and consumables

 

By Source Type:

Mammalian cell line

Non-mammalian cell line

 

By End User:

Biopharmaceutical Companies

Contract Research Organizations

Academics and Research Institutes

Biotechnology Companies

 

By Cell Lines:

Recombinant cell lines

Hybridomas

Continuous cell lines

Primary cell lines

 

By Region:

North America

Latin America

Asia Pacific

Europe

Middle East

Africa

 

Cell Line Development Market Key Players

Some of the key participating players in global Cell Line Development market are:

American Type Culture Collection

Lonza Group AG

Thermo Fisher Scientific, Inc.

GE Healthcare

Sigma Aldrich Corporation

Selexis SA

European Collection of Cell Cultures (ECACC)

Corning, Inc.

Wuxi App Tec, Inc.

Sartorious AG

Factors that are benchmarked while estimating the market

Various factors that are benchmarked while estimating the market growth includes (but not restricted to):

New product designs and launches

Current product compliance

Reimbursement

Concerns for use of Cell Line Development

Advantages of Cell Line Development

Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to take informed decision.

A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment like wherein one/two manufacturer(s) dominates the market, it’s product sales, previous growth rates and market expansion plans are considered to generate market share in the market.


Cell Line Development Market

To learn more about this report, request a free sample copy


1.    Global Cell Line Development Market Report Overview

1.1.    Introduction

1.2.    Report Description

1.3.    Methodology

2.    Global Cell Line Development Market Overview

2.1.    Introduction

2.1.1.    Introduction

2.1.2.    Market Taxonomy

2.2.    Executive Summary

2.3.    Global Cell Line Development Market Snapshot

2.4.    Global Cell Line Development Market Size And Forecast, 2020–2028

2.4.1.    Introduction

2.4.2.    Market Value Forecast And Annual Growth Rate (AGR) Comparison (2020–2028)

2.5.    Global Cell Line Development Market Dynamics

2.5.1.    Drivers

2.5.2.    Restraints

2.5.3.    Opportunity

2.5.4.    Trends

2.6.    Porter’s Five Forces Model

2.7.    SWOT Analysis

2.8.    PEST Analysis

2.9.    Pricing Analysis

3.    Cell Line Development Assessment and Analysis

3.1.    Cell Line Development Impact Analysis 

3.2.    Pipeline Analysis

3.3.    Recent Key Developments

4.    Covid-19 Impact on Cell Line Development Market

4.1.    Impact Analysis of Covid-19 on the global Cell Line Development market

4.2.    Effect On Value Chain

4.3.    Business Impact W.R.T Revenue 

4.4.    Volatility In Price 

4.5.    Effect On The Overall Trade 

4.6.    Market Impact Analysis In 2020 (Quarter Wise)

5.    Global Cell Line Development Market, By Product Type 

5.1.    Introduction

5.1.1.    Annual Growth Rate Comparison, By Product Type

5.1.2.    BPS Analysis, By Product Type

5.2.    Market Revenue (US$Mn) and Forecast, By Product Type

5.2.1.    Reagent and Media

5.2.2.    Equipment

5.2.3.    Accessories and consumables

5.3.    Global Cell Line Development Market Attractiveness Index, By Product Type

6.    Global Cell Line Development Market, By Source Type 

6.1.    Introduction

6.1.1.    Annual Growth Rate Comparison, By Source Type

6.1.2.    BPS Analysis, By Source Type

6.2.    Market Revenue (US$Mn) and Forecast, By Source Type

6.2.1.    Mammalian Cell Line

6.2.2.    Non-Mammalian Cell Line

6.3.    Global Cell Line Development Market Attractiveness Index, By Source Type

7.    Global Cell Line Development Market, By End User 

7.1.    Introduction

7.1.1.    Annual Growth Rate Comparison, By End User

7.1.2.    BPS Analysis, By End User

7.2.    Market Revenue (US$Mn) and Forecast, By End User

7.2.1.    Biopharmaceutical Companies

7.2.2.    Contract Research Organizations

7.2.3.    Academics and Research Institutes

7.2.4.    Biotechnology Companies

7.3.    Global Cell Line Development Market Attractiveness Index, By End User

8.    Global Cell Line Development Market, By Cell Lines 

8.1.    Introduction

8.1.1.    Annual Growth Rate Comparison, By Cell Lines

8.1.2.    BPS Analysis, By Cell Lines

8.2.    Market Revenue (US$Mn) and Forecast, By Cell Lines

8.2.1.    Recombinant Cell Lines

8.2.2.    Hybridomas

8.2.3.    Continuous Cell Lines

8.2.4.    Primary Cell Lines

8.3.    Global Cell Line Development Market Attractiveness Index, By Cell Lines

9.    North America Cell Line Development Market Analysis and Forecast, 2020–2028

9.1.    Introduction

9.1.1.    Annual Growth Rate Comparison, By Country

9.1.2.    BPS Analysis, By Country

9.2.    Market Revenue (US$Mn) and Forecast, By Country

9.2.1.    U.S. Cell Line Development Market

9.2.2.    Canada Cell Line Development Market

9.3.    North America Cell Line Development Market, By Product Type

9.3.1.    Reagent and Media

9.3.2.    Equipment

9.3.3.    Accessories and consumables

9.4.    North America Cell Line Development Market, By Source Type

9.4.1.    Mammalian Cell Line

9.4.2.    Non-Mammalian Cell Line

9.5.    North America Cell Line Development Market, By End User

9.5.1.    Biopharmaceutical Companies

9.5.2.    Contract Research Organizations

9.5.3.    Academics and Research Institutes

9.5.4.    Biotechnology Companies

9.6.    North America Cell Line Development Market, By Cell Lines

9.6.1.    Recombinant Cell Lines

9.6.2.    Hybridomas

9.6.3.    Continuous Cell Lines

9.6.4.    Primary Cell Lines

9.7.    North America Cell Line Development Market Attractiveness Index

9.7.1.    By Country

9.7.2.    By Product Type

9.7.3.    By Source Type

9.7.4.    By End User

9.7.5.    By Cell Lines

10.    Latin America Cell Line Development Market Analysis and Forecast, 2020–2028

10.1.    Introduction

10.1.1.    Annual Growth Rate Comparison, By Country

10.1.2.    BPS Analysis, By Country

10.2.    Market (US$Mn) Forecast, By Country

10.2.1.    Brazil Cell Line Development Market

10.2.2.    Mexico Cell Line Development Market

10.2.3.    Rest Of Latin America Cell Line Development Market

10.3.    Latin America Cell Line Development Market, By Product Type

10.3.1.    Reagent and Media

10.3.2.    Equipment

10.3.3.    Accessories and consumables

10.4.    Latin America Cell Line Development Market, By Source Type

10.4.1.    Mammalian Cell Line

10.4.2.    Non-Mammalian Cell Line

10.5.    Latin America Cell Line Development Market, By End User

10.5.1.    Biopharmaceutical Companies

10.5.2.    Contract Research Organizations

10.5.3.    Academics and Research Institutes

10.5.4.    Biotechnology Companies

10.6.    Latin America Cell Line Development Market, By Cell Lines

10.6.1.    Recombinant Cell Lines

10.6.2.    Hybridomas

10.6.3.    Continuous Cell Lines

10.6.4.    Primary Cell Lines

10.7.    Latin America Cell Line Development Market Attractiveness Index

10.7.1.    By Country

10.7.2.    By Product Type

10.7.3.    By Source Type

10.7.4.    By End User

10.7.5.    By Cell Lines

11.    Europe Cell Line Development Market Analysis and Forecast, 2020–2028

11.1.    Introduction

11.1.1.    Annual Growth Rate Comparison, By Country

11.1.2.    BPS Analysis, By Country

11.2.    Market (US$Mn) Forecast, By Country

11.2.1.    U.K. Cell Line Development Market

11.2.2.    Germany Cell Line Development Market

11.2.3.    Italy Cell Line Development Market

11.2.4.    France Cell Line Development Market

11.2.5.    Spain Cell Line Development Market

11.2.6.    Russia Cell Line Development Market

11.2.7.    BENELUX Cell Line Development Market

11.2.8.    NORDIC Cell Line Development Market

11.2.9.    Poland Cell Line Development Market

11.2.10.    Rest Of Europe Cell Line Development Market

11.3.    Europe Cell Line Development Market, By Product Type

11.3.1.    Reagent and Media

11.3.2.    Equipment

11.3.3.    Accessories and consumables

11.4.    Europe Cell Line Development Market, By Source Type

11.4.1.    Mammalian Cell Line

11.4.2.    Non-Mammalian Cell Line

11.5.    Europe Cell Line Development Market, By End User

11.5.1.    Biopharmaceutical Companies

11.5.2.    Contract Research Organizations

11.5.3.    Academics and Research Institutes

11.5.4.    Biotechnology Companies

11.6.    Europe Cell Line Development Market, By Cell Lines

11.6.1.    Recombinant Cell Lines

11.6.2.    Hybridomas

11.6.3.    Continuous Cell Lines

11.6.4.    Primary Cell Lines

11.7.    Europe Cell Line Development Market Attractiveness Index

11.7.1.    By Country

11.7.2.    By Product Type

11.7.3.    By Source Type

11.7.4.    By End User

11.7.5.    By Cell Lines

12.    Asia Pacific Cell Line Development Market Analysis and Forecast, 2020–2028

12.1.    Introduction

12.1.1.    Annual Growth Rate Comparison, By Country

12.1.2.    BPS Analysis, By Country

12.2.    Market (US$Mn) Forecast, By Country

12.2.1.    China Cell Line Development Market

12.2.2.    India Cell Line Development Market

12.2.3.    Japan Cell Line Development Market

12.2.4.    Australia and New Zealand Cell Line Development Market

12.2.5.    South Korea Cell Line Development Market

12.2.6.    Rest of Asia Pacific Cell Line Development Market

12.3.    Asia Pacific Cell Line Development Market, By Product Type

12.3.1.    Reagent and Media

12.3.2.    Equipment

12.3.3.    Accessories and consumables

12.4.    Asia Pacific Cell Line Development Market, By Source Type

12.4.1.    Mammalian Cell Line

12.4.2.    Non-Mammalian Cell Line

12.5.    Asia Pacific Cell Line Development Market, By End User

12.5.1.    Biopharmaceutical Companies

12.5.2.    Contract Research Organizations

12.5.3.    Academics and Research Institutes

12.5.4.    Biotechnology Companies

12.6.    Asia Pacific Cell Line Development Market, By Cell Lines

12.6.1.    Recombinant Cell Lines

12.6.2.    Hybridomas

12.6.3.    Continuous Cell Lines

12.6.4.    Primary Cell Lines

12.7.    Asia Pacific Cell Line Development Market Attractiveness Index

12.7.1.    By Country

12.7.2.    By Product Type

12.7.3.    By Source Type

12.7.4.    By End User

12.7.5.    By Cell Lines

13.    Middle East Cell Line Development Market Analysis and Forecast, 2020–2028

13.1.    Introduction

13.1.1.    Annual Growth Rate Comparison, By Country

13.1.2.    BPS Analysis, By Country

13.2.    Market (US$Mn) Forecast, By Country

13.2.1.    GCC Countries Cell Line Development Market

13.2.2.    Israel Cell Line Development Market

13.2.3.    Rest Of Middle East Cell Line Development Market

13.3.    Middle East Cell Line Development Market, By Product Type

13.3.1.    Reagent and Media

13.3.2.    Equipment

13.3.3.    Accessories and consumables

13.4.    Middle East Cell Line Development Market, By Source Type

13.4.1.    Mammalian Cell Line

13.4.2.    Non-Mammalian Cell Line

13.5.    Middle East Cell Line Development Market, By End User

13.5.1.    Biopharmaceutical Companies

13.5.2.    Contract Research Organizations

13.5.3.    Academics and Research Institutes

13.5.4.    Biotechnology Companies

13.6.    Middle East Cell Line Development Market, By Cell Lines

13.6.1.    Recombinant Cell Lines

13.6.2.    Hybridomas

13.6.3.    Continuous Cell Lines

13.6.4.    Primary Cell Lines

13.7.    Middle East Cell Line Development Market Attractiveness Index

13.7.1.    By Country

13.7.2.    By Product Type

13.7.3.    By Source Type

13.7.4.    By End User

13.7.5.    By Cell Lines

14.    Africa Cell Line Development Market Analysis and Forecast, 2020–2028

14.1.    Introduction

14.1.1.    Annual Growth Rate Comparison, By Country

14.1.2.    BPS Analysis, By Country

14.2.    Market (US$Mn) Forecast, By Country

14.2.1.    South Africa Countries Cell Line Development Market

14.2.2.    Egypt Cell Line Development Market

14.2.3.    North Africa Cell Line Development Market

14.2.4.    Rest of Africa Cell Line Development Market

14.3.    Africa Cell Line Development Market, By Product Type

14.3.1.    Reagent and Media

14.3.2.    Equipment

14.3.3.    Accessories and consumables

14.4.    Africa Cell Line Development Market, By Source Type

14.4.1.    Mammalian Cell Line

14.4.2.    Non-Mammalian Cell Line

14.5.    Africa Cell Line Development Market, By End User

14.5.1.    Biopharmaceutical Companies

14.5.2.    Contract Research Organizations

14.5.3.    Academics and Research Institutes

14.5.4.    Biotechnology Companies

14.6.    Africa Cell Line Development Market, By Cell Lines

14.6.1.    Recombinant Cell Lines

14.6.2.    Hybridomas

14.6.3.    Continuous Cell Lines

14.6.4.    Primary Cell Lines

14.7.    Africa Cell Line Development Market Attractiveness Index

14.7.1.    By Country

14.7.2.    By Product Type

14.7.3.    By Source Type

14.7.4.    By End User

14.7.5.    By Cell Lines

15.    Competitive Landscape

15.1.    Competition Dashboard

15.2.    Company Share Analysis

15.3.    Market Presence Analysis

15.4.    Company Profiles

15.4.1.    American Type Culture Collection

15.4.1.1.    Company Overview

15.4.1.2.    Financial Overview

15.4.1.3.    Key Developments

15.4.1.4.    Strategies

15.4.1.5.    Product Analysis

15.4.2.    Lonza Group AG

15.4.3.    Thermo Fisher Scientific, Inc.

15.4.4.    GE Healthcare

15.4.5.    Sigma Aldrich Corporation

15.4.6.    Selexis SA

15.4.7.    European Collection of Cell Cultures (ECACC)

15.4.8.    Corning, Inc.

15.4.9.    Wuxi App Tec, Inc.

15.4.10.    Sartorious AG

16.    Acronyms

Select License Type

Frequently Asked Questions

In 2020, global cell line development market was valued at US$ XXX Mn and expected to grow significantly at a CAGR of XXX % over the forecast period

Global Increase in Demand for Monoclonal Antibodies, Innovative Technologies Accelerating the Scale-Up of Cell Lines, and Rise in Vaccine Production are the key factors driving the growth of market

The global Cell Line Development market is segmented on the basis of product type, source type, end user, cell lines, and region

Some of the key participating players in global Cell Line Development market are American Type Culture Collection, Lonza Group AG, Thermo Fisher Scientific, Inc., GE Healthcare, Sigma Aldrich Corporation, Selexis SA, European Collection of Cell Cultures (ECACC), Corning, Inc., and Wuxi App Tec, Inc. Sartorious AG